(Press-News.org) A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries. The research, published online by Nature Immunology on January 8, 2012, explains why cholesterol-laden, coronary artery disease-causing cells called macrophages, accumulate in artery plaques.
"We have discovered that macrophages that accumulate in plaques secrete a molecule called netrin-1," said Kathryn J. Moore, PhD, senior author of the study and associate professor in the Departments of Medicine and Cell Biology at NYU Langone Medical Center. "Our study shows that netrin-1 blocks the normal migration of macrophages out of arteries, causing these immune cells to accumulate and promote the progression of atherosclerosis."
Artery plaques that break off causing vessel blockages, or potentially fatal heart attacks and strokes are known to have high macrophage cell content. Atherosclerosis is fueled by the presence of these cholesterol-laden macrophages in the artery wall. Typically, the immune system sends macrophages to clean up cholesterol deposits in arteries, but once they fill up with the unhealthy form of cholesterol they get stuck in the arteries, triggering the body's inflammatory response. The bloated macrophages then become major components of plaque lining artery walls. Until now, the mechanism by which macrophages become trapped has remained unknown.
In this new study, researchers show why macrophages remain in artery plaques leading to atherosclerosis. Netrin-1 promotes atherosclerosis by retaining macrophages in the artery wall. In fact, netrin-1 signals macrophages to stop migrating and as a result these cells accumulate within the plaque. In addition, study experiments show, genetically deleting netrin-1 can minimize atherosclerosis, reduce the level of macrophages in plaque and promote the migration of macrophages from plaques.
In the study researchers used a florescent tracking technique to label and monitor the movement of macrophage cells in and out of plaques. This experiment showed how macrophages were immobilized and retained in plaque by netrin-1 expression and also demonstrated macrophage emigration from plaque after the deletion of netrin-1.
"Our study identifies netrin-1 as a novel target for future therapeutic intervention for the treatment of atherosclerosis and cardiovascular disease," said Janine M. van Gils, PhD, lead author of the study and a post-doctoral researcher in the Marc and Ruti Bell Vascular Biology and Disease Program, Leon H. Charney Division of Cardiology, Department of Medicine at NYU Langone Medical Center. "This discovery provides new clues to help reduce the amount of plaque in arteries and the threat of atherosclerosis, a major cause of mortality in Western countries. The development of a new strategy to diminish macrophage accumulation in plaque offers great promise to reducing the occurrence of fatal cardiac events."
INFORMATION:
The study was a collaboration between NYU School of Medicine, Massachusetts General Hospital, Harvard Medical School, Federal University of Monas Gerais, Belo Horizonte in Brazil and the University of Washington. The study was supported by the American Heart Association, the National Institutes of Health, the Heart and Stroke Foundation of Canada and the Conselho Nacional Desenvolvimento Cientifico e Tecnologico.
About NYU Langone Medical Center
NYU Langone Medical Center, a world-class, patient-centered, integrated, academic medical center, is one on the nation's premier centers for excellence in clinical care, biomedical research and medical education. Located in the heart of Manhattan, NYU Langone is composed of three hospitals – Tisch Hospital, its flagship acute care facility; the Rusk Institute of Rehabilitation Medicine, the world's first university-affiliated facility devoted entirely to rehabilitation medicine; and the Hospital for Joint Diseases, one of only five hospitals in the nation dedicated to orthopaedics and rheumatology – plus the NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. The medical center's tri-fold mission to serve, teach and discover is achieved 365 days a year through the seamless integration of a culture devoted to excellence in patient care, education and research. For more information, go to www.NYULMC.org.
END
St. Louis Society for the Blind and Visually Impaired is very pleased to announce it has been selected to participate in the "Year of Making a Difference" program presented by Gallop, a major law firm headquartered in St. Louis. (www.GallopLaw.com).
"Year of Making a Difference" is a unique charitable awareness and fundraising initiative managed by Gallop that will benefit not only Society for the Blind and Visually Impaired but additional non-profit organizations in St. Louis that assist people right here in our community.
David Ekin, President ...
A new form of graphene created by researchers at The University of Texas at Austin could prevent laptops and other electronics from overheating, ultimately, overcoming one of the largest hurdles to building smaller and more powerful electronic devices.
The research team, which includes colleagues at The University of Texas at Dallas, the University of California-Riverside and Xiamen University in China, published its findings online today in the Advance Online Publication of Nature Materials. The study will also appear in the print journal of Nature Materials.
Led ...
In the chemistry of the living world, a pair of nucleic acids—DNA and RNA—reign supreme. As carrier molecules of the genetic code, they provide all organisms with a mechanism for faithfully reproducing themselves as well as generating the myriad proteins vital to living systems.
Yet according to John Chaput, a researcher at the Center for Evolutionary Medicine and Informatics, at Arizona State University's Biodesign Institute®, it may not always have been so.
Chaput and other researchers studying the first tentative flickering of life on earth have investigated various ...
FloraTerra, California's based landscape management company, has announced the addition of Larry Petretti as their new Operations Manager in their San Jose Branch. Petretti, has over 25 Years' experience in the Green Industry, beginning his career in horticulture working with several successful landscape companies throughout the San Francisco Bay Area.
He worked at Delconte Landscape in Fremont as there District Manager, and at the beginning of his career with Western Landscapes in 1986 he has spent his past 6 years as a successful self-employed entrepreneur relocating ...
A new study has found that when parents get tested for breast cancer genes, many of them share their results with their children, even with those who are very young. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that most parents think that their children are not distressed when they learn about the test results.
For parents, one of the primary motivations for getting tested for hereditary cancer genes is to better understand the risk that their children face; however, many parents struggle with the decision ...
Acupuncture and sham acupuncture appear equally effective in treating migraines, according to a clinical trial published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj110551.pdf.
An international team of researchers conducted a randomized controlled trial to determine the effect of acupuncture compared with sham acupuncture in treating migraines in 480 patients at nine hospitals in China. The patients were randomly assigned to four groups, including one sham acupuncture group and three groups receiving different ...
A new study suggests that middle-aged adults recently diagnosed with diabetes and hypertension have time to try to learn how to control their high blood pressure without medications, but not too much time.
The consequences of delaying effective hypertension treatment for up to a year were small—a two-day reduction in quality-adjusted life expectancy—according to a study by University of Chicago researchers published online for the Journal of General Internal Medicine. But as the delay gets longer, the damages multiply. A ten-year delay decreased life expectancy by almost ...
Award Winning International Branding and Consumer Product Development Firm to Launch Products in Spring-2012
Florence, KY Geoff Ficke, President of Duquesa Marketing announced today that his Firm has been retained to act as Managing Consultants for the creation, testing Branding and market introduction of Dr. Ajit Nemi's line of targeted skin treatment products.
"Ajit Nemi MD MBA is a brilliant young doctor and researcher who has built a thriving Eye Care practice in the Atlanta area", said Mr. Ficke. "His extensive work with patients provides Dr. Nemi ...
The main symptom of Rotor syndrome is jaundice caused by a buildup of a substance known as conjugated bilirubin. Bilirubin is a yellow substance generated in large quantities when the body recycles red blood cells. It is conjugated in the liver to make it soluble in water so that it can be cleared from the body. Although Rotor syndrome is known to be a genetic disorder, it is not known which genes are involved. However, a team of researchers — led by Alfred Schinkel, at The Netherlands Cancer Institute, The Netherlands; and Milan Jirsa, at the Institute for Clinical and ...
Hereditary spastic paraplegias (HSPs) are a group of inherited neurodegenerative disorders characterized by progressive weakness and spasticity (stiffness) of the legs. Mutations in more than 30 genes have been linked to HSPs. A team of researchers — led by Stephan Züchner, at the University of Miami Miller School of Medicine, Miami; Evan Reid, at the University of Cambridge, United Kingdom; and Antonio Orlacchio, at the Centro Europeo di Ricerca sul Cervello–Istituto di Ricovero e Cura a Carattere Scientifico Santa Lucia, Italy — has now associated mutations in the gene ...
